Opexa Therapeutics (OPXA) – Hot FDA News
-
Opexa Therapeutics' (OPXA) Phase 2b Abili-T Trial of Tcelnaa in Secondary Progressive MS Misses Primary Endpoint
-
Opexa Therapeutics (OPXA) Jumps On Positive FDA Meetings on Tovaxin
Back to OPXA Stock Lookup